These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

253 related items for PubMed ID: 16143423

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Favorable outcomes of autoimmune hepatitis in a community clinic setting.
    Seo S, Toutounjian R, Conrad A, Blatt L, Tong MJ.
    J Gastroenterol Hepatol; 2008 Sep; 23(9):1410-4. PubMed ID: 18373564
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Autoimmune hepatitis type 1: safety and efficacy of prolonged medical therapy.
    Seela S, Sheela H, Boyer JL.
    Liver Int; 2005 Aug; 25(4):734-9. PubMed ID: 15998423
    [Abstract] [Full Text] [Related]

  • 6. Predictive factors for remission and death in 73 patients with autoimmune hepatitis in Japan.
    Hino T, Kumashiro R, Ide T, Koga Y, Ishii K, Tanaka E, Morita Y, Hisamochi A, Murashima S, Tanaka K, Ogata K, Kuwahara R, Sata M, Autoimmune Hepatitis Study Group.
    Int J Mol Med; 2003 Jun; 11(6):749-55. PubMed ID: 12736717
    [Abstract] [Full Text] [Related]

  • 7. Long-term outcomes of patients with autoimmune hepatitis managed at a nontransplant center.
    Hoeroldt B, McFarlane E, Dube A, Basumani P, Karajeh M, Campbell MJ, Gleeson D.
    Gastroenterology; 2011 Jun; 140(7):1980-9. PubMed ID: 21396370
    [Abstract] [Full Text] [Related]

  • 8. Clinical features of Japanese male patients with type 1 autoimmune hepatitis.
    Miyake Y, Iwasaki Y, Sakaguchi K, Shiratori Y.
    Aliment Pharmacol Ther; 2006 Aug 01; 24(3):519-23. PubMed ID: 16886918
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Disease progression in Chinese chronic hepatitis C patients with persistently normal alanine aminotransaminase levels.
    Hui CK, Zhang HY, Shek T, Yao H, Yueng YH, Leung KW, Lai ST, Lai JY, Leung N, Lau GK.
    Aliment Pharmacol Ther; 2007 Jun 01; 25(11):1283-92. PubMed ID: 17509096
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Reversibility of cirrhosis in autoimmune hepatitis.
    Malekzadeh R, Mohamadnejad M, Nasseri-Moghaddam S, Rakhshani N, Tavangar SM, Sohrabpour AA, Tahaghoghi S.
    Am J Med; 2004 Jul 15; 117(2):125-9. PubMed ID: 15234650
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Risk factors for recurrence of autoimmune hepatitis after liver transplantation.
    Montano-Loza AJ, Mason AL, Ma M, Bastiampillai RJ, Bain VG, Tandon P.
    Liver Transpl; 2009 Oct 15; 15(10):1254-61. PubMed ID: 19790153
    [Abstract] [Full Text] [Related]

  • 18. Autoimmune hepatitis with acute presentation in Japan.
    Miyake Y, Iwasaki Y, Kobashi H, Yasunaka T, Ikeda F, Takaki A, Yamamoto K.
    Dig Liver Dis; 2010 Jan 15; 42(1):51-4. PubMed ID: 19473895
    [Abstract] [Full Text] [Related]

  • 19. Changes in liver histology as a "surrogate" end point of antiviral therapy for chronic HBV can predict progression to liver complications.
    Hui CK, Leung N, Shek WH, Zhang HY, Luk JM, Poon RT, Lo CM, Fan ST, Lau GK, Hong Kong Liver Fibrosis Study Group.
    J Clin Gastroenterol; 2008 Jan 15; 42(5):533-8. PubMed ID: 18344885
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.